In a recent letter to the editor of the Louisville Courier-Journal, Kentucky Horsemen's Benevolent and Protective Association executive director Marty Maline suggested that the scientific evidence behind 19 of the 26 thresholds suggested by the Racing Medication and Testing Consortium is lacking. This week, Dr. Dionne Benson, executive director of the RMTC took to the paper with an editorial of her own, rebutting Maline's claims.
Benson stated that the RMTC oversees medication administration studies and contracts analytical chemistry work to help establish appropriate thresholds ofmedication in Thoroughbreds. The majority of those studies, many of which are done in collaboration with international scientists, are peer-reviewed, Benson stated, and many of them have appeared in peer-reviewed journals. All of them, she wrote, are reviewed by a 12-17 member scientific advisory committee.
Maline had written that trainers and veterinarians feel it's a matter of crossing their fingers, hoping for negative tests since they have the impression that environmental contamination can cause a positive test against sensitive thresholds. He cited the case of trainer Daniel Werre, who had a horse test positive for levamisole because it stabled next to a horse that was receiving the drug as treatment for equine protozoal myelitis (EPM). Werre appealed the positive handed to him, contesting that the Kentucky commission's classification of the drug was inappropriate given its legitimate usage, and won.
Read Benson's editorial here.
Read Maline's editorial here.
New to the Paulick Report? Click here to sign up for our daily email newsletter to keep up on this and other stories happening in the Thoroughbred industry.
Copyright © 2019 Paulick Report.